Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Molecular Prognostic Model”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableUnknownNCT06279832
What this trial is testing

Radiomics and Radiogenomics Models to Predict Molecular Integrated Risk Classes and Prognostic Factors in Endometrial Cancer.

Who this might be right for
Endometrial Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,000
Not applicableStudy completedNCT07180966
What this trial is testing

Development and Validation of the Surgical Assessment and Healthcare (SAH) Index for Gastric Cancer Treatment Evaluation

Who this might be right for
Gastric Cancer (GC)
Ruijin Hospital 780
Not applicableStudy completedNCT06720454
What this trial is testing

Study on Single-cell Regulons Atlas of Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Molecular Prognostic ModelRegulons
Tiejun Ying 68
Not applicableLooking for participantsNCT07608003
What this trial is testing

Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:

Who this might be right for
Gliomas Harboring IDH1 and/or IDH2 MutationsGlioma Glioblastoma MultiformeGlioma of Brainstem+3 more
Xiangya Hospital of Central South University 500
Not applicableLooking for participantsNCT01676805
What this trial is testing

Tissue Collection for Studies of Lymph Cancer

Who this might be right for
Hodgkin DiseaseLymphoma, Non-HodgkinMultiple Myeloma+2 more
National Cancer Institute (NCI) 1,295
Not applicableUnknownNCT03089099
What this trial is testing

Expression of Molecular Markers in Circulating Tumor Cells of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Fudan University 100